Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 

Question 4: Long-term Objective C

green dot 4LC. Conduct at least one study to evaluate the safety and effectiveness of medications commonly used in the treatment of co-occurring conditions or specific behavioral issues in people with ASD by 2015. IACC Recommended Budget: $10,000,000 over 5 years.

Projects Found: 7
Total Funding: 2302240
Project Title Funding Funding Institution

Project Title

Mirtazapine treatment of anxiety in children and adolescents with pervasive developmental disorders
$99,974

Funding

99974

Institution

Indiana University

Project Title

Pharmacotherapy of pervasive developmental disorders
$184,587

Funding

184587

Institution

Indiana University-Purdue University Indianapolis

Project Title

2/4-RUPP autism network: Guanfacine for the treatment of hyperactivity in PDD
$325,136

Funding

325136

Institution

Seattle Children's Hospital

Project Title

1/4-RUPP autism network: Guanfacine for the treatment of hyperactivity in PDD
$366,035

Funding

366035

Institution

Indiana University-Purdue University Indianapolis

Project Title

Targeted pharmacologic interventions for autism
$370,481

Funding

370481

Institution

Indiana University-Purdue University Indianapolis

Project Title

3/4-RUPP autism network: Guanfacine for the treatment of hyperactivity in PDD
$391,103

Funding

391103

Institution

University of California, Los Angeles

Project Title

4/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD
$564,924

Funding

564924

Institution

Yale University

 
Back to Top